Form 4: Processa Pharmaceuticals CAO Wendy Guy Increases Stake

Chief Administrative Officer Wendy Guy acquired 1,583 shares of Processa Pharmaceuticals common stock at $2.97 per share.

Summary

• Wendy Guy, Chief Administrative Officer of Processa Pharmaceuticals, Inc. (PCSA), purchased 1,583 shares of common stock.
• The transaction occurred on April 15, 2026, at a price of $2.97 per share.
• Following this transaction, Wendy Guy directly owns 4,693 shares of common stock.
• The reporting person also maintains an indirect interest in 333 shares held by CorLyst, LLC.

Sentiment

Score: 6

Explanation: StockSavvy.ai views this as a mildly positive signal, as it reflects internal confidence from a key executive without indicating a major strategic shift.

Positives

• Insider confidence is demonstrated by the Chief Administrative Officer increasing her equity position in the company.

Negatives

• None noted in this filing.

Risks

• None noted in this filing.

Future Outlook

Not applicable as this is a standard insider transaction report.

Industry Context

StockSavvy.ai notes that insider buying is generally viewed as a positive signal of management's belief in the company's long-term prospects, particularly in the volatile biotechnology sector.

Comparison to Industry Standards

• Insider purchases are common among small-cap biotech firms to signal alignment with shareholder interests.

Related Party Transactions

• The reporting person maintains an indirect interest in 333 shares held by CorLyst, LLC.

Stakeholder Impact

• Shareholders may view the insider purchase as a sign of stability and confidence from the Chief Administrative Officer.

Next Steps

• No future actions or milestones were mentioned in this filing.

Key Dates

Keywords

Processa Pharmaceuticals, PCSA, Insider Trading, Form 4, Wendy Guy, Equity Acquisition